(RTTNews) - MiNK Therapeutics (INKT), a clinical-stage company, said new translational data supporting the role of invariant natural killer T or iNKT cells in idiopathic pulmonary fibrosis or IPF were ...
When the founder of one of America’s top-selling wine brands roasted himself, it captured the tone for an unexpectedly hopeful event. Here’s what happened at the 2026 Unified Wine & Grape Symposium.
Abstract: The Internet of Things (IoT) devices have become increasingly widespread in recent years. Since IoT devices tend to suffer from attacks from the Internet, they need monitoring using ...
Cellino, a regenerative medicine company developing autonomous manufacturing systems for personalized cells, today announced that the company has been invited to speak at iPSCs: Progress, ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cellino, a regenerative medicine company developing autonomous manufacturing systems for personalized cells, today announced that the company has been invited to ...
Meeting co-organized by Nobel Laureate Dr. Shinya Yamanaka, discoverer of induced pluripotent stem cells, Yanhong Shi, Ph.D., and Yasushi Kajii, Ph.D. Cellino, a regenerative medicine company ...
SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other ...
Nimacimab is a potential first-in-class, peripherally-restricted monoclonal antibody inhibitor of the CB1 receptor. Unlike previous CB1-targeting drugs, nimacimab is designed to avoid central nervous ...
Colton Jones, M.D., of The University of Texas San Antonio, discusses aspirin for colorectal cancer prevention after presenting research comparing GLP-1s with aspirin at the 2026 ASCO Gastrointestinal ...
The Columbia girls basketball team’s 2025-26 campaign started with injuries. However, the Raiders stand on top of the Lorain County League after Jan. 5. In an LC8 rivalry matchup with Keystone, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results